captopril has been researched along with oxidopamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; Luo, HY; Wu, ZY; Yang, K; Zhou, Q | 1 |
| Gan, EK; Latiff, A; Sattar, MA | 1 |
| Aravich, PF; Blair, ML; Devine, MA; Felten, SY; Sladek, CD | 1 |
| Correa, JG; Stoppani, AO | 1 |
| Albino-Teixeira, A; Morato, M; Sousa, T | 1 |
| Labandeira-Garcia, JL; Lopez-Real, A; Mendez-Alvarez, E; Rey, P; Soto-Otero, R | 1 |
6 other study(ies) available for captopril and oxidopamine
| Article | Year |
|---|---|
[Central norepinephrine and angiotensin II contents in the brain regions of spontaneously hypertensive rats (SHR) and the interaction between them].
Topics: Angiotensin II; Animals; Blood Pressure; Brain; Captopril; Hypertension; Norepinephrine; Oxidopamine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1991 |
Effect of captopril on converting enzyme activity in chemically sympathectomized, spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Hydroxydopamines; Hypertension; Male; Oxidopamine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathectomy, Chemical | 1985 |
Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Brain; Captopril; Catecholamines; Hydroxydopamines; Hypertension; Hypothalamo-Hypophyseal System; Oxidopamine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasopressins | 1988 |
Catecholamines enhance dihydrolipoamide dehydrogenase inactivation by the copper Fenton system. Enzyme protection by copper chelators.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding Sites; Captopril; Catecholamines; Catechols; Cattle; Chelating Agents; Copper; Cysteine; Dihydrolipoamide Dehydrogenase; Dopamine; Epinephrine; Hydrogen Peroxide; Hydroxyl Radical; Iron; Kinetics; Mammals; Norepinephrine; Oxidation-Reduction; Oxidopamine; Penicillamine | 1996 |
Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Body Weight; Captopril; Cell Size; Heart; Hypertension; Hypertrophy; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Organ Size; Oxidopamine; Peptidyl-Dipeptidase A; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Sympathectomy; Sympatholytics; Tail; Xanthines | 2002 |
Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dopamine; Immunohistochemistry; Injections, Intraventricular; Lipid Peroxidation; Male; Mesencephalon; Neostriatum; Nerve Tissue Proteins; Neurons; Oxidation-Reduction; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Sympatholytics; Thiobarbituric Acid Reactive Substances | 2005 |